John M. D. Storey

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Serge Gauthier, Howard Feldman, Lon S. Schneider et al. · The Lancet · 2016 · 405 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Pharmacology +10

Electrically Tunable Selective Reflection of Light from Ultraviolet to Visible and Infrared by Heliconical Cholesterics

Jie Xiang, Yannian Li, Quan Li et al. · Advanced Materials · 2015 · 327 citations · Full text

Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease

Claude M. Wischik, Roger T. Staff, Damon Wischik et al. · Journal of Alzheimer s Disease · 2015 · 251 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Biochemistry +15

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Gordon Wilcock, Serge Gauthier, Giovanni B. Frisoni et al. · Journal of Alzheimer s Disease · 2017 · 210 citations · Full text

Understanding the twist-bend nematic phase: the characterisation of 1-(4-cyanobiphenyl-4′-yloxy)-6-(4-cyanobiphenyl-4′-yl)hexane (CB6OCB) and comparison with CB7CB

Daniel A. Paterson, Min Gao, Young‐Ki Kim et al. · Soft Matter · 2016 · 202 citations · Full text

Materials Science, Crystal Structure, Molecular Dynamics +15